Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal metastases: analysis of short- and long-term outcomes.

Fausto RosaFederica GaliandroRiccardo RicciDario Di MiceliGiuseppe QueroClaudio FiorilloCaterina CinaSergio Alfieri

Published in: Langenbeck's archives of surgery (2021)

CRS and HIPEC for limited peritoneal metastases from CRC are safe and effective, with acceptable morbidity. In selected patients, it offers a highly favorable long-term outcomes.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
minimally invasive
prognostic factors
peritoneal dialysis
coronary artery bypass
patient reported outcomes
radiation therapy
atrial fibrillation
surgical site infection